Abstract
In the process of optimization, we developed a novel core skeleton of thieno[3,4-b]pyrazine viaGK-13. The derivatives synthesized were shown to inhibit TGase 2 activity in cancer cells. Some of the hit compounds such as the arylethynyl group-coupled thieno[3,4-b]pyrazine derivatives were shown to exhibit promising activity for use as potential therapeutic small-molecules in renal cancer by inhibiting TGase 2 activity. This journal is
Original language | English |
---|---|
Pages (from-to) | 4932-4940 |
Number of pages | 9 |
Journal | Organic and Biomolecular Chemistry |
Volume | 12 |
Issue number | 27 |
DOIs | |
State | Published - 21 Jul 2014 |